NCT05929469 is a NA clinical trial of App in Overweight, sponsored by University of North Carolina, Chapel Hill.

Who is sponsoring NCT05929469?

NCT05929469 is sponsored by University of North Carolina, Chapel Hill.

What drugs are being tested in NCT05929469?

Interventions in NCT05929469: App, Fully Automated Kick-Off, Human-Enhanced Kick-Off, Check-In, Counseling.

What condition does NCT05929469 study?

NCT05929469 studies Overweight, Obesity, Overweight and Obesity.

Is NCT05929469 still recruiting?

NCT05929469 is currently completed. Last updated 30 May 2024.

Last reviewed 2024-05-30 · How we verify

NCT05929469

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches

Completed NA Last updated 30 May 2024

What this trial tests

NA trial testing App in Overweight in 99 participants. Completed in 25 April 2024.

Timeline

2 October 2023

Primary endpoint
25 April 2024

25 April 2024

Quick facts

Lead sponsor	University of North Carolina, Chapel Hill
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	none
Primary purpose	treatment
Enrollment	99
Start date	2 October 2023
Primary completion	25 April 2024
Estimated completion	25 April 2024
Sites	1 location across United States

Drugs / interventions tested

App
Fully Automated Kick-Off
Human-Enhanced Kick-Off
Check-In
Counseling

Conditions studied

Overweight — all drugs for Overweight →
Obesity — all drugs for Obesity →
Overweight and Obesity — all drugs for Overweight and Obesity →

Sponsor

University of North Carolina, Chapel Hill

Who can join

Adults 18 to 65, any sex, with Overweight or Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this initial pilot and feasibility study is to test different digital, behavioral weight loss approaches, with or without human support, using a sequential, multiple assignment, randomized trial (SMART) design. All participants in this pilot trial will receive a 3-month mobile health (mHealth) program. The dose of human support will vary by first- and second-line randomizations. The feasibility, acceptability, and preliminary outcomes for each of the treatment sequences will be assessed.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Results of a pilot sequential multiple assignment randomized trial using counseling to augment a digital weight loss program.
Martinez CE, Nezami BT, Mayer-Davis E, Willis EA, et al · · 2024 · PMID 39512729 · DOI 10.1002/osp4.70018

Verify or expand the search:

Other trials of App

Trials testing the same drug.

NCT06833736 — A Health App Using Recipes and Education Components to Facilitate Sustainable and Healthier Diets. · NA · completed
NCT06045390 — An App-based Instructional Platform to Improve Eye Drop Recall · NA · completed
NCT06083545 — The Effects of Application Intervention on the Physiological Indicators and Low Protein Diet Cognition Among the Patient · NA · unknown
NCT05690971 — Psychosocial Mobile App for Chronic Graft-Versus-Host Disease · NA · active not recruiting
NCT05792488 — Lifestyle Guidance Methods in NAFLD · NA · completed

Other recruiting trials for Overweight

Currently open trials in the same condition.

NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07472881 — Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women · NA · recruiting
NCT07465965 — A Clinical Study of Semaglutide Nasal Spray in Overweight or Obese Adults · Phase 1 · recruiting
NCT07407348 — A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the · Phase 1 · recruiting
NCT07400653 — A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) · Phase 3 · recruiting

Other University of North Carolina, Chapel Hill trials

Trials by the same sponsor.

NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05929469 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
Last refreshed: 30 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05929469.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing